Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QLS-101 vs Timolol in POAG or OHT
NCT04830397Phase 2Completed
- Start
- Mar 2021
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of foslevcromakalim in primary open-angle glaucoma (POAG), ocular hypertension. Started Mar 2021; status: completed.
02
Drugs
foslevcromakalim
03
Conditions
primary open-angle glaucoma (POAG)ocular hypertension
Beyond the preview
Go deeper on NCT04830397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04830397.